Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Curarimimetic   Cisatracurium besylate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Bensitrak Mexico
Besilato de cisatracurio Colombia
Cicuryl Mexico
Cirium Colombia
Cis Atracure Egypt
Cisatracurio Spain
Cisatracurium Belgium, Canada
Nimbex Australia, Austria, Belgium, Canada, Chile, Denmark, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iran, Ireland, Italy, Luxembourg, Malaysia, Netherlands, Norway, Poland, Portugal, Saudi Arabia, Spain, Sweden, Tunisia, Turkey, United Arab Emirates, United States of America, Venezuela
Nimbium Colombia
Stability in solutions   Injection   Stability in solutions : Cisatracurium besylate     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass None 10 mg/ml 2-8°C Protect from light
450 Day
4769
Level of evidence A+
Glass None 2 & 10 mg/ml 23°C With or without light
45 Day
533
Level of evidence A+
Glass None 2 & 10 mg/ml 4°C Protect from light
90 Day
533
Level of evidence A+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,1 & 2 & 5 mg/ml 4°C Protect from light
30 Day
533
Level of evidence A+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 mg/ml 23°C With or without light
30 Day
533
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,1 mg/ml 23-27°C Not specified
48 Hour
4358
Level of evidence C+
Polyolefine Sodium chloride 0,9% 0,1 mg/ml 4-6°C Not specified
7 Day
4358
Level of evidence C+
Polyolefine Glucose 5% 0,1 mg/ml 23-27°C Not specified
24 Hour
4358
Level of evidence C+
Polyolefine Glucose 5% 0,1 mg/ml 4-6°C Not specified
7 Day
4358
Level of evidence C+
Polypropylen Syringe Sodium chloride 0,9% 0,1 mg/ml 23-27°C Not specified
2 Day
4358
Level of evidence C+
Polypropylen Syringe Sodium chloride 0,9% 0,1 mg/ml 4-6°C Not specified
7 Day
4358
Level of evidence C+
Polypropylen Syringe Glucose 5% 0,1 mg/ml 23-27°C Not specified
2 Day
4358
Level of evidence C+
Polypropylen Syringe Glucose 5% 0,1 mg/ml 4-6°C Not specified
2 Day
4358
Level of evidence C+
Polypropylen Syringe None 2 mg/ml 23-27°C Not specified
7 Day
4358
Level of evidence C+
Polypropylen Syringe None 2 mg/ml 23°C With or without light
30 Day
533
Level of evidence A+
Polypropylen Syringe None 2 mg/ml 4-6°C Not specified
7 Day
4358
Level of evidence C+
Polypropylen Syringe None 2 mg/ml 4°C Protect from light
30 Day
533
Level of evidence A+
Polypropylen Syringe None 5 mg/ml 23-27°C Not specified
7 Day
4358
Level of evidence C+
Polypropylen Syringe None 5 mg/ml 4-6°C Not specified
7 Day
4358
Level of evidence C+
  Mentions Légales